Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
Blokhin's Russian Cancer Research Center
Tempus AI
NGM Biopharmaceuticals, Inc